Syria coronavirus spike sees hospitals reach capacity

coronavirus
Credit: Pixabay/CC0 Public Domain

Hospitals in the Syrian capital Damascus and the coastal province of Latakia have reached capacity due to rising coronavirus admissions, a health official said Sunday.

“We have started transferring COVID-19 patients from the of Damascus to the (central) province of Homs, and from Latakia to the province of Tartus,” Tawfiq Hasaba, a ministry official, was quoted as saying by Syrian state TV.

The move came after “hospitals in these areas reached capacity because of a large spike in coronavirus cases,” he added.

Syria on Saturday logged 442 new coronavirus infections in government-held areas—a new daily record for a conflict-hit country that has documented more than 32,580 cases, including 2,198 deaths in regime controlled territory, since the start of its outbreak last year.

“It is the first time the number of cases reaches 400” in one day, Hasaba said, adding that the number of new infections was highest in Damascus, Aleppo and Latakia.

Coronavirus cases have been on the rise across Syria since mid-August, including in the northwest and northeast, large parts of which fall beyond .

According to the World Health Organization, only two percent of Syria’s population has been at least partially vaccinated.

Syria’s conflict has since 2011 killed nearly half a million people and ravaged a healthcare sector struggling to cope with a mass outflux of professionals.

Around 70 percent of the country’s pre-war have left since the start of the war.



© 2021 AFP

Citation: Syria coronavirus spike sees hospitals reach capacity (2021, September 26) retrieved 2 October 2021 from https://medicalxpress.com/news/2021-09-syria-coronavirus-spike-hospitals-capacity.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Note: This article have been indexed to our site. We do not claim ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
India reveals latest digital health projects thumbnail

India reveals latest digital health projects

The Indian government has announced two new projects to promote digital health for its citizens as it continues to battle the ongoing COVID-19 pandemic. Delivering her speech for the Union Budget 2022-2023, Finance Minister Nirmala Sitharaman said the government will be launching an open platform connecting the country's digital health ecosystem under the Ayushman Bharat…
Read More
These zodiac signs never get tired of work thumbnail

These zodiac signs never get tired of work

These zodiac signs are often associated with an unwavering commitment to hard work and an insatiable drive for success.Capricorns are known for their strong work ethic, discipline, and ambition. They are driven by their desire for success to achieve their goals.Capricorn Taurus individuals are reliable and persistent. They are often very dedicated to their work and
Read More
Quantifying Alcohol's Death Risk; NDAs Hide Docs' Mistakes; H5N1 Pandemic Prep thumbnail

Quantifying Alcohol’s Death Risk; NDAs Hide Docs’ Mistakes; H5N1 Pandemic Prep

Special Reports > Features — This past week in healthcare investigations by Sophie Putka, Enterprise & Investigative Writer, MedPage Today June 18, 2024 Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. Quantifying Alcohol's Death Risk Increasingly, research is coming out in favor of drinking
Read More
Slow start to the year as expected thumbnail

Slow start to the year as expected

Group sales stable at 14.389 billion euros (Fx & portfolio adj. minus 1.1 percent)o   Accelerated normalization in glyphosate business – good price dynamics in other Crop Science unitso   New Pharmaceuticals products deliver strong growth – headwinds in Chinao   Consumer Health continues to growEBITDA before special items: 4.471 billion euros (minus 14.9 percent)o   Glyphosate and inflation weigh on earningso   Pharmaceuticals
Read More
Index Of News
Total
0
Share